关注
Daniel George
Daniel George
未知所在单位机构
在 duke.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Abiraterone in metastatic prostate cancer without previous chemotherapy
CJ Ryan, MR Smith, JS De Bono, A Molina, CJ Logothetis, P De Souza, ...
New England Journal of Medicine 368 (2), 138-148, 2013
32102013
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal …
RJ Motzer, MD Michaelson, BG Redman, GR Hudes, G Wilding, RA Figlin, ...
Journal of Clinical Oncology 24 (1), 16-24, 2006
21422006
Sunitinib in patients with metastatic renal cell carcinoma
RJ Motzer, BI Rini, RM Bukowski, BD Curti, DJ George, GR Hudes, ...
Jama 295 (21), 2516-2524, 2006
16132006
Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3
HI Scher, MJ Morris, WM Stadler, C Higano, E Basch, K Fizazi, ...
Journal of Clinical Oncology 34 (12), 1402, 2016
13272016
Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy
A Ravaud, RJ Motzer, HS Pandha, DJ George, AJ Pantuck, A Patel, ...
New england journal of medicine 375 (23), 2246-2254, 2016
8042016
Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the alliance A031203 CABOSUN trial
TK Choueiri, S Halabi, BL Sanford, O Hahn, MD Michaelson, MK Walsh, ...
Journal of Clinical Oncology 35 (6), 591, 2017
7982017
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
JB Nelson, SP Hedican, DJ George, AH Reddi, S Piantadosi, ...
Nature medicine 1 (9), 944-949, 1995
7851995
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers
AJ Armstrong, MS Marengo, S Oltean, G Kemeny, RL Bitting, JD Turnbull, ...
Molecular cancer research 9 (8), 997-1007, 2011
7732011
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer
G Agnelli, DJ George, AK Kakkar, W Fisher, MR Lassen, P Mismetti, ...
New England Journal of Medicine 366 (7), 601-609, 2012
6442012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate …
WK Kelly, S Halabi, M Carducci, D George, JF Mahoney, WM Stadler, ...
Journal of Clinical Oncology 30 (13), 1534, 2012
5052012
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma
BI Rini, MD Michaelson, JE Rosenberg, RM Bukowski, JA Sosman, ...
Journal of Clinical Oncology 26 (22), 3743-3748, 2008
4892008
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
AJ Armstrong, S Halabi, T Eisen, S Broderick, WM Stadler, RJ Jones, ...
The Lancet Oncology 17 (3), 378-388, 2016
4192016
Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free …
TK Choueiri, C Hessel, S Halabi, B Sanford, MD Michaelson, O Hahn, ...
European journal of cancer 94, 115-125, 2018
3942018
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes
RH Vonderheide, SM Domchek, JL Schultze, DJ George, KM Hoar, ...
Clinical Cancer Research 10 (3), 828-839, 2004
3542004
Oral relugolix for androgen-deprivation therapy in advanced prostate cancer
ND Shore, F Saad, MS Cookson, DJ George, DR Saltzstein, R Tutrone, ...
New England Journal of Medicine 382 (23), 2187-2196, 2020
3512020
Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma
L Ellis, Y Pan, GK Smyth, DJ George, C McCormack, R Williams-Truax, ...
Clinical Cancer Research 14 (14), 4500-4510, 2008
3462008
Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model
PK Majumder, JJ Yeh, DJ George, PG Febbo, J Kum, Q Xue, R Bikoff, ...
Proceedings of the National Academy of Sciences 100 (13), 7841-7846, 2003
3352003
Prospective multicenter validation of androgen receptor splice variant 7 and hormone therapy resistance in high-risk castration-resistant prostate cancer: the PROPHECY study
AJ Armstrong, S Halabi, J Luo, DM Nanus, P Giannakakou, ...
Journal of Clinical Oncology 37 (13), 1120, 2019
3112019
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480
DJ George, S Halabi, TF Shepard, NJ Vogelzang, DF Hayes, EJ Small, ...
Clinical cancer research 7 (7), 1932-1936, 2001
2952001
Sunitinib efficacy against advanced renal cell carcinoma
RJ Motzer, MD Michaelson, J Rosenberg, RM Bukowski, BD Curti, ...
The Journal of urology 178 (5), 1883-1887, 2007
2642007
系统目前无法执行此操作,请稍后再试。
文章 1–20